JADPRO Live 2024
Find important meeting news and updates from JADPRO Live 2024, the Annual APSHO Meeting, held November 14-17, in Grapevine, Texas. The meeting features panel discussions, abstracts, posters, and education sessions for oncology nurses and advanced practitioners.
Adrienne Duckworth, MSN, APRN, NP-C, AOCNP, discusses how the initiative improved the lung cancer screening rate to 27%.
Christa Braun-Inglis, DNP, APRN, FNP-BC, AOCNP, discusses the development and implementation of the program.
A quantitative-qualitative survey provided insights on patient experiences, emotions, and perceptions
Research presented at JADPRO Live provided insights into patient preferences surrounding treatment administration.
The workshop aimed to help advanced practitioners recognize imaging findings and communicate results to patients.
Cara Fleming, AGPCNP-BC, shares insights from the project she presented at JADPRO Live.
Melissa Rosen, MA, explains how advanced practitioners can help connect patients with the organization and its resources.
The meeting featured a full agenda with multiple opportunities to connect with colleagues, share ideas, and get inspired.
Dr. Ehsan discusses the importance of preventing nausea and vomiting during cancer treatment and shares his approach.
The award honors an APSHO member who demonstrates exemplary leadership and makes outstanding contributions.
Josie Montegaard, NP, shares highlights and reflects on the importance of attending JADPRO Live, the Annual APSHO Meeting.
Sanita Burgic, MSN, APRN, AGNP-C, discusses key takeaways from her JADPRO Live presentation on updates in breast cancer.
Erin M. Pierce, MSN, APRN, FNP-C, discusses key takeaways and shares insights from the workshop at JADPRO Live.
The implementation of the process showed that outpatient administration is safe, well-tolerated, and reduced inpatient days.
The post hoc study analysis showed that optimized bridging therapy is critical to disease control for multiple myeloma.
Research presented at JADPRO Live 2024 illuminated the diagnostic experiences of patients with colorectal cancer.
Researchers studied DARA plus VRd as a new standard of care vs VRd alone in patients with newly-diagnosed multiple myeloma.
The workshop provided education and resources on providing cancer care for adolescents and young adults.
Researchers presented the results of the intervention program at JADPRO Live, the Annual APSHO Meeting.
The Patient Navigation Center at the Multiple Myeloma Research Foundation addresses barriers to care and supports patients.
Talquetamab showed "robust and durable responses" for patients with relapsed/refractory multiple myeloma.
Hear expert insights on how APPs can play a key role in expanding access to clinical trials and promoting diversity.
Theresa Wicklin Gillespie, PhD, MA, RN, FAAN, discusses her workshop on improving clinical trial representation and access.
The meeting, which will be held from November 14-17 in Grapevine, Texas, features a “jam-packed” agenda.
Advertisement
Advertisement
© 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.